Clinical translation of immunoliposomes for cancer therapy: recent perspectives.
作者： Di Wang , Yating Sun , Yange Liu , Fanchao Meng , Robert J. Lee
DOI: 10.1080/17425247.2018.1517747
关键词:
摘要: Introduction: Liposomes have been extensively investigated as drug delivery vehicles. Immunoliposomes (ILs) are antibody-conjugated liposomes designed to selectively target antigen-expressing cells...
sci-hub.se 参考文章(85)
Roland E Kontermann, Immunoliposomes for cancer therapy. Current Opinion in Molecular Therapeutics. ,vol. 8, pp. 39- 45 ,(2006)
B. M. Bradt, G. R. Mirick, S. J. Denardo, Gerald L Denardo, A review of human anti-globulin antibody (HAGA, HAMA, HACA, HAHA) responses to monoclonal antibodies. Not four letter words. Quarterly Journal of Nuclear Medicine and Molecular Imaging. ,vol. 48, pp. 251- 257 ,(2004)
Judith A Smith, Anthony B Costales, Mona Jaffari, Diana L Urbauer, Michael Frumovitz, Christine K Kutac, Huyentran Tran, Robert L Coleman, Is it equivalent? Evaluation of the clinical activity of single agent Lipodox® compared to single agent Doxil® in ovarian cancer treatment. Journal of Oncology Pharmacy Practice. ,vol. 22, pp. 599- 604 ,(2016) , 10.1177/1078155215594415
Hitoshi Soda, Hiromichi Maeda, Junichi Hasegawa, Takao Takahashi, Shoichi Hazama, Mutsumi Fukunaga, Emiko Kono, Masahito Kotaka, Junichi Sakamoto, Naoki Nagata, Koji Oba, Hideyuki Mishima, Multicenter Phase II study of FOLFOX or biweekly XELOX and Erbitux (cetuximab) as first-line therapy in patients with wild-type KRAS/BRAF metastatic colorectal cancer: The FLEET study. BMC Cancer. ,vol. 15, pp. 695- 695 ,(2015) , 10.1186/S12885-015-1685-Z
Pierre Simard, Jean-Christophe Leroux, pH-sensitive immunoliposomes specific to the CD33 cell surface antigen of leukemic cells. International Journal of Pharmaceutics. ,vol. 381, pp. 86- 96 ,(2009) , 10.1016/J.IJPHARM.2009.05.013
M Le Garff-Tavernier, L Herbi, C de Romeuf, F Nguyen-Khac, F Davi, A Grelier, M Boudjoghra, K Maloum, S Choquet, R Urbain, V Vieillard, H Merle-Béral, Antibody-dependent cellular cytotoxicity of the optimized anti-CD20 monoclonal antibody ublituximab on chronic lymphocytic leukemia cells with the 17p deletion. Leukemia. ,vol. 28, pp. 230- 233 ,(2014) , 10.1038/LEU.2013.240
Bo Yu, Shu-Hao Hsu, Chenguang Zhou, Xinmei Wang, Megan C. Terp, Yun Wu, Lesheng Teng, Yicheng Mao, Feng Wang, Weiming Xue, Samson T. Jacob, Kalpana Ghoshal, Robert J. Lee, Ly J. Lee, Lipid nanoparticles for hepatic delivery of small interfering RNA Biomaterials. ,vol. 33, pp. 5924- 5934 ,(2012) , 10.1016/J.BIOMATERIALS.2012.05.002
JD Sims, M Taguaim, C Hanson, X Cui, LK Medina-Kauwe, Abstract P5-08-08: A human epidermal growth factor receptor 3 (HER3)-binding nanoparticle targets and kills Herceptin®-resistant human epidermal growth factor receptor 2 (HER2)-positive breast cancer Cancer Research. ,vol. 73, ,(2013) , 10.1158/0008-5472.SABCS13-P5-08-08
Samir Mitragotri, Paul A. Burke, Robert Langer, Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies Nature Reviews Drug Discovery. ,vol. 13, pp. 655- 672 ,(2014) , 10.1038/NRD4363
John C. Kraft, Jennifer P. Freeling, Ziyao. Wang, Rodney J.Y. Ho, Emerging Research and Clinical Development Trends of Liposome and Lipid Nanoparticle Drug Delivery Systems Journal of Pharmaceutical Sciences. ,vol. 103, pp. 29- 52 ,(2014) , 10.1002/JPS.23773